StonvexLoading…
StonvexStonvexStonvexCore line items from AXON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-06-30 | Annual 2024 2024-03-31 |
|---|---|---|---|---|
Revenue | $2.78B | $2.08B | $503.24M | $459.87M |
Operating Income | $-62.08M | $58.54M | $33.76M | $16.46M |
Net Income | $124.66M | $377.03M | $41.47M | $133.35M |
EPS (Diluted) | $1.51 | $4.80 | $0.53 | $1.73 |
Total Assets | $7.00B | $4.47B | Not available | $3.59B |
Total Liabilities | $3.76B | $2.15B | Not available | $1.76B |
Cash & Equivalents | $1.20B | $454.84M | Not available | Not available |
Free Cash Flow OCF − CapEx | $75.08M | $329.53M | Not available | Not available |
Shares Outstanding | 80.21M | 76.62M | Not available | Not available |